HomeHealthcare & Life Sciences Guanylate Cyclase C Agonist Market

Guanylate Cyclase C Agonist Market Size, Share, Demand Report By Drug Type (Linaclotide, Plecanatide), By Application (IBS-C, Chronic Idiopathic Constipation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Clinics, Homecare Settings), By Region & Segment Forecasts, 2026–2034

Starting From
USD 3950
Buy Now

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.

  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.

  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.

  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

  • Track sales in the global and country-specific Market.

  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: Guanylate Cyclase C Agonist Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on Guanylate Cyclase C Agonist Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. Guanylate Cyclase C Agonist Market, Drug Type
    1. Introduction
      1. Market Size and Forecast, Drug Type
    2. Linaclotide
      1. Market Size and Forecast, By Region
    3. Plecanatide
      1. Market Size and Forecast, By Region
  10. Guanylate Cyclase C Agonist Market, Application
    1. Introduction
      1. Market Size and Forecast, Application
    2. Irritable Bowel Syndrome with Constipation (IBS-C)
      1. Market Size and Forecast, By Region
    3. Chronic Idiopathic Constipation (CIC)
      1. Market Size and Forecast, By Region
  11. Guanylate Cyclase C Agonist Market, Distribution Channel
    1. Introduction
      1. Market Size and Forecast, Distribution Channel
    2. Hospital Pharmacies
      1. Market Size and Forecast, By Region
    3. Retail Pharmacies
      1. Market Size and Forecast, By Region
    4. Online Pharmacies
      1. Market Size and Forecast, By Region
  12. Guanylate Cyclase C Agonist Market, End User
    1. Introduction
      1. Market Size and Forecast, End User
    2. Hospitals
      1. Market Size and Forecast, By Region
    3. Clinics
      1. Market Size and Forecast, By Region
    4. Homecare Settings
      1. Market Size and Forecast, By Region
  13. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. North America
      1. Market Size and Forecast
        1. Drug Type
          1. Linaclotide
            1. Plecanatide
            2. Application
              1. Irritable Bowel Syndrome with Constipation (IBS-C)
                1. Chronic Idiopathic Constipation (CIC)
                2. Distribution Channel
                  1. Hospital Pharmacies
                    1. Retail Pharmacies
                      1. Online Pharmacies
                      2. End User
                        1. Hospitals
                          1. Clinics
                            1. Homecare Settings
                          2. U.S.
                            1. Drug Type
                              1. Linaclotide
                                1. Plecanatide
                                2. Application
                                  1. Irritable Bowel Syndrome with Constipation (IBS-C)
                                    1. Chronic Idiopathic Constipation (CIC)
                                    2. Distribution Channel
                                      1. Hospital Pharmacies
                                        1. Retail Pharmacies
                                          1. Online Pharmacies
                                          2. End User
                                            1. Hospitals
                                              1. Clinics
                                                1. Homecare Settings
                                              2. Canada
                                            2. Europe
                                              1. Market Size and Forecast
                                                1. Drug Type
                                                  1. Linaclotide
                                                    1. Plecanatide
                                                    2. Application
                                                      1. Irritable Bowel Syndrome with Constipation (IBS-C)
                                                        1. Chronic Idiopathic Constipation (CIC)
                                                        2. Distribution Channel
                                                          1. Hospital Pharmacies
                                                            1. Retail Pharmacies
                                                              1. Online Pharmacies
                                                              2. End User
                                                                1. Hospitals
                                                                  1. Clinics
                                                                    1. Homecare Settings
                                                                  2. U.K.
                                                                    1. Drug Type
                                                                      1. Linaclotide
                                                                        1. Plecanatide
                                                                        2. Application
                                                                          1. Irritable Bowel Syndrome with Constipation (IBS-C)
                                                                            1. Chronic Idiopathic Constipation (CIC)
                                                                            2. Distribution Channel
                                                                              1. Hospital Pharmacies
                                                                                1. Retail Pharmacies
                                                                                  1. Online Pharmacies
                                                                                  2. End User
                                                                                    1. Hospitals
                                                                                      1. Clinics
                                                                                        1. Homecare Settings
                                                                                      2. Germany
                                                                                      3. France
                                                                                      4. Spain
                                                                                      5. Italy
                                                                                      6. Russia
                                                                                      7. Nordic
                                                                                      8. Benelux
                                                                                      9. Rest of Europe
                                                                                    2. APAC
                                                                                      1. Market Size and Forecast
                                                                                        1. Drug Type
                                                                                          1. Linaclotide
                                                                                            1. Plecanatide
                                                                                            2. Application
                                                                                              1. Irritable Bowel Syndrome with Constipation (IBS-C)
                                                                                                1. Chronic Idiopathic Constipation (CIC)
                                                                                                2. Distribution Channel
                                                                                                  1. Hospital Pharmacies
                                                                                                    1. Retail Pharmacies
                                                                                                      1. Online Pharmacies
                                                                                                      2. End User
                                                                                                        1. Hospitals
                                                                                                          1. Clinics
                                                                                                            1. Homecare Settings
                                                                                                          2. China
                                                                                                            1. Drug Type
                                                                                                              1. Linaclotide
                                                                                                                1. Plecanatide
                                                                                                                2. Application
                                                                                                                  1. Irritable Bowel Syndrome with Constipation (IBS-C)
                                                                                                                    1. Chronic Idiopathic Constipation (CIC)
                                                                                                                    2. Distribution Channel
                                                                                                                      1. Hospital Pharmacies
                                                                                                                        1. Retail Pharmacies
                                                                                                                          1. Online Pharmacies
                                                                                                                          2. End User
                                                                                                                            1. Hospitals
                                                                                                                              1. Clinics
                                                                                                                                1. Homecare Settings
                                                                                                                              2. South Korea
                                                                                                                              3. Japan
                                                                                                                              4. India
                                                                                                                              5. Australia
                                                                                                                              6. Singapore
                                                                                                                              7. Taiwan
                                                                                                                              8. South East Asia
                                                                                                                              9. Rest of Asia-Pacific
                                                                                                                            2. Middle East and Africa
                                                                                                                              1. Market Size and Forecast
                                                                                                                                1. Drug Type
                                                                                                                                  1. Linaclotide
                                                                                                                                    1. Plecanatide
                                                                                                                                    2. Application
                                                                                                                                      1. Irritable Bowel Syndrome with Constipation (IBS-C)
                                                                                                                                        1. Chronic Idiopathic Constipation (CIC)
                                                                                                                                        2. Distribution Channel
                                                                                                                                          1. Hospital Pharmacies
                                                                                                                                            1. Retail Pharmacies
                                                                                                                                              1. Online Pharmacies
                                                                                                                                              2. End User
                                                                                                                                                1. Hospitals
                                                                                                                                                  1. Clinics
                                                                                                                                                    1. Homecare Settings
                                                                                                                                                  2. UAE
                                                                                                                                                    1. Drug Type
                                                                                                                                                      1. Linaclotide
                                                                                                                                                        1. Plecanatide
                                                                                                                                                        2. Application
                                                                                                                                                          1. Irritable Bowel Syndrome with Constipation (IBS-C)
                                                                                                                                                            1. Chronic Idiopathic Constipation (CIC)
                                                                                                                                                            2. Distribution Channel
                                                                                                                                                              1. Hospital Pharmacies
                                                                                                                                                                1. Retail Pharmacies
                                                                                                                                                                  1. Online Pharmacies
                                                                                                                                                                  2. End User
                                                                                                                                                                    1. Hospitals
                                                                                                                                                                      1. Clinics
                                                                                                                                                                        1. Homecare Settings
                                                                                                                                                                      2. Turky
                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                      4. South Africa
                                                                                                                                                                      5. Egypt
                                                                                                                                                                      6. Nigeria
                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                    2. LATAM
                                                                                                                                                                      1. Market Size and Forecast
                                                                                                                                                                        1. Drug Type
                                                                                                                                                                          1. Linaclotide
                                                                                                                                                                            1. Plecanatide
                                                                                                                                                                            2. Application
                                                                                                                                                                              1. Irritable Bowel Syndrome with Constipation (IBS-C)
                                                                                                                                                                                1. Chronic Idiopathic Constipation (CIC)
                                                                                                                                                                                2. Distribution Channel
                                                                                                                                                                                  1. Hospital Pharmacies
                                                                                                                                                                                    1. Retail Pharmacies
                                                                                                                                                                                      1. Online Pharmacies
                                                                                                                                                                                      2. End User
                                                                                                                                                                                        1. Hospitals
                                                                                                                                                                                          1. Clinics
                                                                                                                                                                                            1. Homecare Settings
                                                                                                                                                                                          2. Brazil
                                                                                                                                                                                            1. Drug Type
                                                                                                                                                                                              1. Linaclotide
                                                                                                                                                                                                1. Plecanatide
                                                                                                                                                                                                2. Application
                                                                                                                                                                                                  1. Irritable Bowel Syndrome with Constipation (IBS-C)
                                                                                                                                                                                                    1. Chronic Idiopathic Constipation (CIC)
                                                                                                                                                                                                    2. Distribution Channel
                                                                                                                                                                                                      1. Hospital Pharmacies
                                                                                                                                                                                                        1. Retail Pharmacies
                                                                                                                                                                                                          1. Online Pharmacies
                                                                                                                                                                                                          2. End User
                                                                                                                                                                                                            1. Hospitals
                                                                                                                                                                                                              1. Clinics
                                                                                                                                                                                                                1. Homecare Settings
                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                              6. Rest of LATAM
                                                                                                                                                                                                          3. Competitive Landscape, 2025
                                                                                                                                                                                                            1. Introduction
                                                                                                                                                                                                            2. Guanylate Cyclase C Agonist Market Share Analysis, 2025 (%)
                                                                                                                                                                                                              1. Market Share Analysis, 2025
                                                                                                                                                                                                              2. Competition Ranking, 2025
                                                                                                                                                                                                              3. Key Developments & Growth Strategies
                                                                                                                                                                                                                1. Merger & Acquisition
                                                                                                                                                                                                                2. Product Launch
                                                                                                                                                                                                                3. Expansion
                                                                                                                                                                                                              4. Consolidated SWOT Analysis of Key Players
                                                                                                                                                                                                          4. Company Profile
                                                                                                                                                                                                            1. Ironwood Pharmaceuticals Inc.
                                                                                                                                                                                                              1. Business Overview
                                                                                                                                                                                                              2. Financial Data
                                                                                                                                                                                                              3. Key Product Categories
                                                                                                                                                                                                              4. Recent Developments
                                                                                                                                                                                                            2. Astellas Pharma Inc.
                                                                                                                                                                                                            3. Takeda Pharmaceutical Company Limited
                                                                                                                                                                                                            4. AstraZeneca plc
                                                                                                                                                                                                            5. Pfizer Inc.
                                                                                                                                                                                                            6. Johnson & Johnson
                                                                                                                                                                                                            7. Novartis AG
                                                                                                                                                                                                            8. Sanofi S.A.
                                                                                                                                                                                                            9. GlaxoSmithKline plc
                                                                                                                                                                                                            10. Bayer AG
                                                                                                                                                                                                            11. Merck & Co. Inc.
                                                                                                                                                                                                            12. AbbVie Inc.
                                                                                                                                                                                                            13. Eli Lilly and Company
                                                                                                                                                                                                            14. Synergy Pharmaceuticals Inc.
                                                                                                                                                                                                            15. Allergan plc